CONCEPT DOCUMENT © Ed Broadbent 2026. Independent work product | Peer-led national architecture | View Hub Overview →

Harm Reduction Hub — National Signal Register

Peer-Led National Drug Signal Intelligence
Mindframe-aligned language
National signal network under AIVL peer-led governance
Federated across all states and territories via RSS

Signal Overview

National early warning signals across all jurisdictions — substances, locations, and reasons for concern under peer-led governance

Substances Detected in Signals
Signals by Jurisdiction
Signal Volume — Monthly Trend
Reason for Concern
Recent Drug Alerts — Prompt Response Network

Drug Alerts Feed

Published alerts from national and jurisdictional drug checking and health services

The Know NSW Health VPTS CanTEST QLD Health
About this feed: Drug alerts are sourced via RSS from The Know, state and territory health departments, and drug checking services including CanTEST and VPTS. AIVL peer-led governance determines alert distribution tiers. In production, RSS feeds update every 60 minutes — subscribers (peer networks, AOD services, mental health services, PHNs) receive filtered alerts calibrated to their role and jurisdiction.

Signal Register

National signal intelligence across all jurisdictions — substances detected, statistical areas, and reasons for concern. Community-governed, peer-reported.

How signals work: Signals are generated from multiple data sources — peer reports, emergency department presentations, drug checking services, coronial data, and frontline service reports. Each signal captures the substance(s) detected, the statistical area (SA3), and the reason for concern. All jurisdictions contribute equally under AIVL's federated governance model. Signals flow through the Hub's cyclical pentagon: Individual → Community → Health → Research → Government.

Reports & Resources

Published drug alerts, national resources, and key references for the AOD sector

Published Drug Alerts

Drug alerts published through the Prompt Response Network via The Know. Each alert contains substance identification, risk context, and harm reduction guidance.

National Resources
Key National References

Governance Architecture

Cyclical peer-led governance under AIVL stewardship — governance as architecture, not afterthought. Community governs; institutions contribute.

Hub Peer-Led Governance

The Hub's governance model is cyclical: signals flow through five dimensions (Individual → Community → Health → Research → Government) and governance flows outward from the centre through tiered access. AIVL as national peak body holds structural authority. State and territory peer organisations form the federated network.

Hub Information Sharing Tiers

Six-tier information sharing framework governing data access, disclosure, and use across the Hub network. Access is granted by community governance, not assumed by institutional affiliation. RSS feeds distribute tier-appropriate intelligence to subscribers.

National Signal Register — Peer-Led Governance Model

National governance structure for the signal register under AIVL stewardship, connecting peer networks, AOD services, mental health services, and government through clear accountability tiers. Distribution via RSS ensures every stakeholder receives filtered intelligence calibrated to their role.

Governance Principles

Evidence Base

Published research underpinning the Hub's architecture, drawn from NCCRED, AIVL, and international harm reduction literature

The Escalating Context

17
Nitazene Deaths (Coronial)
Confirmed coronial deaths from nitazene toxicity. First detected 2021. Appearing in cocaine, ketamine, benzodiazepines (Clifford et al., 2025).
64
Border Seizures (2023-2024)
Nitazene border seizures by ABF. April 2025: 4kg seizure of a nitazene analogue. 11 nitazenes now Schedule 9 (Clifford et al., 2025).
23
Novel Benzo Alerts (2020-2025)
Nearly half (n=11) issued Jan-Jun 2025 alone. NBZs are the most detected NPS class in Australian ED data (Freestone, Kypri, Schumann et al., 2026).
2,072
CanTEST Samples Tested
50% contained unexpected substances. 10% discarded after testing. 6 world-first detections. 70% of clients had never accessed healthcare for drug info (Olsen et al., 2023).
Nitazenes: Cross-Contamination Pattern
Synthetic opioids with potency orders of magnitude above morphine appearing as contaminants in substances people do not expect to contain opioids: cocaine, ketamine, benzodiazepines. "Nitazenes are now an established feature of the Australian illicit drug market, with 11 nitazenes classified as Schedule 9 (prohibited substance) by the Therapeutic Goods Administration" (Clifford et al., 2025). Standard naloxone doses may be insufficient; multiple doses may be required.
Novel Benzodiazepines: Detection Challenges
Bromazolam, flubromazolam, clobromazolam, ethylbromazolam: substances that do not appear on standard urine drug screens. Only LC-MS can detect them. Clinicians report refusing to treat people using novel benzodiazepines because they lack tapering protocols. Benzodiazepines remain the second-largest drug class implicated in unintentional drug-induced deaths after opioids (Penington Institute, 2025).
Pill Testing: Political Vulnerability
Queensland banned pill testing in September 2025, shutting down CheQpoint services. AMAQ opposes the ban. CanTEST demonstrated the model: 2,072 samples, 30+ alerts, 6 world-first detections, 50% unexpected substances, 10% discarded, 70% first-time healthcare access (Olsen et al., 2023). Infrastructure subject to political cycles can be removed quietly; infrastructure governed by peer peak bodies with statutory recognition is harder to defund without public accountability.
What the Research Recommends
Freestone, Franklin, Broadbent et al. (2025)
NCCRED research brief: "Peer-led organisations and drug checking services are regarded by people who use drugs as credible and trustworthy organisations." Peer-led organisations should be involved at all stages of issuing a public drug warning.
Freestone, Zhou, Kypri et al. (2026) — IJDP
Jointly conceptualised by AIVL and the PRN: "Community reporting initiatives should be led by PWUD; prioritise community engagement; be open to reports of benefits and harms, be underpinned by robust moderation." Conclusion: "Such systems must be underpinned by strong governance... and be led by communities."
Siefried et al. (2025) — Frontiers in Public Health
PRN co-design: mobilisation of diverse disciplinary and community stakeholders toward a unified collaborative response, positioning community mobilisation as foundational rather than supplementary.
AIVL National Research Strategy (2025)
Research about affected communities "is not only informed by lived-living experience but also controlled and led by those it directly impacts." Repositions community from knowledge-translation recipient to governing authority.
Volpe et al. (2023) — Harm Reduction Journal
Five structural tensions in drug alert co-design. Credibility is challenging "in a broader context of criminalisation, stigmatisation, and sensationalism." Community governance is necessary but not sufficient.
Freestone, Kypri, Schumann et al. (2026) — Drug and Alcohol Review
Novel benzodiazepines review: 23 NBZ-related alerts 2020-2025, nearly half in H1 2025. NBZs are the most detected NPS class in Australian ED data. Standard immunoassay screening has limited cross-reactivity with most NBZ analogues.
The Structural Argument
Research Clock Speed
Hypothesis, ethics approval, data collection, peer review, publication, policy translation. Months to years. Essential for building the evidence base. When operational response is housed within a research institution, it inherits the research clock speed. Governance meetings replace field decisions.
Response Clock Speed
Detection, verification, alert, clinical guidance, community notification. Hours to days. Each published PRN Drug Alert Report contains the same limitation: "Currently there are no standardised national reporting guidelines for drug alerts in Australia" (Kypri et al., 2025a, 2025b, 2025c).
Seven Federated Data Streams
Drug Alert Feeds
The Know, state health alerts, AIVL bulletins, PRN reports. RSS distribution expanded The Know's audience tenfold in two months with zero budget.
National Substance Database
NPS tracking, polydrug combinations, alias matching. Multi-name classification mapping street names to standardised chemical identifiers.
Wastewater Analysis
ACIC national monitoring, quarterly. Population-level consumption patterns independent of self-report and clinical presentation biases.
Drug Checking Services
CanTEST, DanceWize, NUAA. Per-sample composition. Real-time intelligence at a tempo institutional reporting cannot match (Olsen et al., 2023).
EDNA Toxicosurveillance
16 emergency departments across 6 states. Clinical presentations with laboratory-confirmed substance identification (Smith et al., 2025).
Emerging Research
PubMed, grey literature, weekly. Pharmacological, epidemiological, and policy research feeding signal interpretation.
Community Forums
"People who use drugs are the first detectors" (Freestone, Franklin, Broadbent et al., 2025). Peer-reported signals with moderation governance.
International Precedents
UNAIDS Community-Led Monitoring (2021)
Formalised CLM for HIV services. Five community-led stages, structural distinction between community participation and community authority.
INPUD CLM for PWUD (2023)
Adapted CLM for drug-using communities. "Community-led" means structural authority, not consultation seats.
TxCOPE (Claborn et al., 2022)
Community-engaged digital health ecosystem for overdose reporting. Four advisory boards, 74 stakeholders, 24 PWUD. "Dismantling the power structure among academic and industry partners is critical."
Sydney MSIC (2001-present)
Legislatively-protected harm reduction operating continuously for 25+ years across successive political environments. Demonstrates political durability of legislated infrastructure.
References

AIVL (2025). Leading the way: a peer-led national research strategy for people who use drugs.

Claborn, K.R. et al. (2022). Ethical by Design. Frontiers in Digital Health, 4, 880849.

Clifford, B. et al. (2025). Responding to reports of nitazene toxicity in Australia. MJA, 222(5).

Freestone, J., Franklin, E., Broadbent, E. et al. (2025). Emerging Best Practices in the Design and Dissemination of Public Drug Warnings. NCCRED, UNSW.

Freestone, J., Kypri, S. et al. (2026). The Emergence of Novel Benzodiazepines in Australia. Drug and Alcohol Review, 45(1).

Freestone, J., Zhou, C. et al. (2026). Incorporating experiential reports provided by PWUD into drug-related EWS. IJDP, 147.

INPUD (2023). Community-led Monitoring for People Who Use Drugs.

Kypri, S. et al. (2025a-c). PRN Drug Alert Reports 2024 Annual, Q1 2025, Q2 2025. NCCRED, UNSW.

Olsen, A. et al. (2023). CanTEST Health and Drug Checking Service Evaluation. ANU.

Penington Institute (2025). Australia's Annual Overdose Report 2025.

Siefried, K.J. et al. (2025). Co-design of the Australian PRN. Frontiers in Public Health, 13.

Smith, K. et al. (2025). EDNA-V. IJDP.

UNAIDS (2021). Establishing community-led monitoring of HIV services.

Volpe, I. et al. (2023). Tensions in the design of drug alerts. Harm Reduction Journal, 20(1).